Michael C. V. Jensen, MD

Childhood cancer doesn’t stand a chance against Dr. Mike Jensen. Director of the Ben Towne Center for Childhood Cancer Research at Seattle Children’s Research Institute, he has refined cellular immunotherapy -- a method of reprogramming a patient’s own immune system -- to kill cancer. This could make chemotherapy and radiation – and their devastating side effects – treatments of the past.

His game-changing research is now being put to the test in clinical trials, and the results are very promising.

Jensen joined Seattle Children’s in 2010 and has written more than 50 research papers, won two Young Investigator Awards, and received more than $2 million in research funding from the National Institutes of Health. He conducted the first FDA-authorized trial of T-cell therapies for children with recurrent neuroblastoma. He was trained at the University of Pennsylvania School of Medicine and completed a fellowship in pediatric hematology-oncology at the University of Washington and the Fred Hutchinson Cancer Research Center.